BRAINLIFE.ORG





Topics


Meningioma | Treatment | Clinical trials | Pembrolizumab






Home > Publications > Topics > Meningioma > Treatment > Clinical trials > Pembrolizumab






Limon D, Amiel A, Even Haim S, Gordon N, Tschernichovsky R, Stemmer S, Gal O, Laviv Y, Kanner A, Siegal T, Yust-Katz S.
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.
Neurooncol Adv. 2024 Sep 16;6(1):vdae154. doi: 10.1093/noajnl/vdae154. PMID: 39429970. Interventional study. ˍ